India's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and Trade Agreement. This groundbreaking agreement removes almost all tariffs on Indian drug products, enhancing the competitiveness of Indian generics and finished formulations. Preliminary data indicates promising trends in exports for this fiscal year, solidifying the UK's importance as a critical European market for India's pharmaceutical sector.

The India-UK Comprehensive Economic and Trade Agreement takes effect on July 15, 2026. This pact grants nearly 99% duty-free access for Indian exports to the United Kingdom.…

The agreement goes beyond tariff cuts and weaves together trade, investment, mobility and regulatory cooperation between two nations

Indian exporters anticipate a surge in UK demand with zero tariffs under CETA, boosting competitiveness in key sectors.

India's new trade pact with the UK offers significant export chances for manufacturers. Lower tariffs will benefit sectors like textiles, leather, and processed foods. Indian…

India UK Free Trade Agreement: The India-UK Comprehensive Economic and Trade Agreement is now in effect. Nearly all Indian exports will gain duty-free access to the United…

Businesses welcome the pact but seek clarity on implementation details and regulations. Technical standards and rules of origin require further guidance for effective trade.…

India exports $140 million duty-free to the UK on Day One of the new trade pact, aiming for $100 billion bilateral trade by 2030.

India and the UK marked a significant step in trade relations on Wednesday by launching a new economic pact enabling zero-duty access for Indian exports to the UK. After…